|
|
Ghana
|
FDA/VVC/251-08033
|
CEVAC MD RISPEN 2000D SUSPENSION FOR INJECTION (MAREK'S DISEASE VACCINE, SEROTYPE 1, LIVE VIRUS MAREK'S DISEASE RISPENS ANTIGEN IS AT LEAST 1608 PFU'S PER DOSE THROUGH EXPIRATION)
|
MAREK'S DISEASE VACCINE, SEROTYPE 1, LIVE VIRUS MAREK'S DISEASE RISPENS ANTIGEN
|
CEVA ANIMAL HEALTH, LLC, 8906 ROSEHILL ROAD LENEXA, KANSAS 66215, USA
|
3 months to expiry
|
Details →
|
|
|
Zambia
|
346/731V
|
Cevac Corymune 4 K vaccine
|
Avibacterium Paragallinarum Serotype A ≥ 7.0 log₁₀ CFU before inactivation unit,Avibacterium Paragallinarum Serotype B ≥ 7.0 log₁₀ CFU before inactivation unit,Avibacterium Paragallinarum Serotype C ≥ 7.0 log₁₀ CFU before inactivation unit,Salmonella enteritidis Induces ≥ 4.0 log₂ MAT titre unit
|
Ceva–Phylaxia Veterinary Biologicals Co. Ltd.
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
346/730V
|
Cevac Corymune 7K Vaccine (Inactivated combination of Avibacterium paragallinarum, serotypes A, B and C, Salmonella enteritidis strain)
|
Newcastle Disease Virus 6log2 HI, Infectious Bronchitis Virus 6log2 HI, Egg Drop Syndrome Virus 7log2 HI, Avibacterium paragallinarum 7log10HI, Salmonella
|
Ceva–Phylaxia Veterinary Biologicals Co. Ltd.
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
346/704V
|
Prid Delta Vaginal delivery system
|
Progesterone 1.55 g
|
Ceva Animal Health (Pty) Ltd
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
346/730V
|
Cevac Corymune 7K vaccine
|
Newcastle Disease virus+ Infectious Bronchitis virus+ Egg Dr
|
Ceva–Phylaxia Veterinary Biologicals Co. Ltd.
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
346/717V
|
Coglavax vaccine
|
Alpha Toxoid Of Clostridium Perfringens Type A 2,0 IU/ml,Alpha Toxoid Of Clostridium Novyi B (OedematÃÂens) 3.5 IU/ml,Anaculture Of Clostridium Chauvoei 90 %,Beta Toxoid Of Clostridium Perfringens Type C 10.0 IU/ml,Epsilon Toxoid Of Clostridium Perfringens Type D 5.0 IU/ml,Toxoid Of Clostridium Septicum 2.5 IU/ml,Toxoid Of Clostridium Tetani 2.5 IU/ml
|
Ceva–Phylaxia Veterinary Biologicals Co. Ltd.
|
Registered/Compliant
|
Details →
|
|
|
South Africa
|
12/17.1.1.2/08
|
CEVAXEL RTU
|
None
|
-
|
Registered
|
Details →
|
|
|
Zambia
|
346/714V
|
Cevaxel RTU suspension for injection
|
Ceftiofur hydrochloride 50.00 mg
|
Ceva Sante Animale
|
Registered/Compliant
|
Details →
|
|
|
South Africa
|
09/3.1.2.2/19
|
CANIFLAM
|
None
|
-
|
Registered
|
Details →
|
|
|
Zambia
|
ZAMRA-VM-23-05
|
Vectormune ND vaccine
|
Mareks Disease HVT FC 126 Strain Min 3420 Units,Newcastle disease virus D-26 lentogenic strain Min 3420 Units
|
Biomune Co
|
Registered/Compliant
|
Details →
|
|
|
Zambia
|
346/732V
|
Vectormune FP-MG + AE Vaccine
|
Mycoplasma gallisepticum virus 102.7 TCID50, Avian encephalomyelitis virus 102.7 TCID50
|
Ceva Animal Health
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TZ 19 V 0024
|
Poximune AE
|
Avian Encephalomyelitis 102.7 TCID50/dose,Fowl pox virus 102.7 TCID50/dose
|
Ceva Animal Health LLC
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 24 VM 0389
|
Vectormune FP-MG
|
Fowl pox-mycoplasma gallisepticum Cutter strain 10^2.7 TCID50
|
Ceva Animal Health LLC
|
Registered/Compliant
|
Details →
|
|
|
South Africa
|
19/5.3/07
|
CARDALIS 10 mg/80 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
South Africa
|
19/5.3/05
|
CARDALIS 2,5 mg/20 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
South Africa
|
19/5.3/06
|
CARDALIS 5 mg/40 mg
|
None
|
-
|
Registered
|
Details →
|
|
|
Ghana
|
FDA/VVC/253-06012
|
VECTOR MUNE FP-MG (FOWL POX-MYCOPLASMA GALLISEPTICAN LIVE FOWL POX VECTOR)
|
FOWL POX-MYCOPLASMA GALLISEPTICAN LIVE FOWL POX VECTOR
|
CEVA ANIMAL HEALTH, LLC 8906 ROSEHILL ROAD LENEXA KANSAS 66215 USA
|
Valid
|
Details →
|
|
|
Zambia
|
346/719V
|
Florkem 300 mg/ml solution for injection
|
Florfenicol 300 mg
|
Ceva Animal Health (Pty) Ltd
|
Registered/Compliant
|
Details →
|
|
|
Ghana
|
FDA/VVC/243-05024
|
Vectormune HVT NDV & Rispens
|
-
|
CEVA ANIMAL HEALTH LLC 8901 ROSEHILL RD LENEXA KANSAS 66215 USA
|
3 months to expiry
|
Details →
|
|
|
South Africa
|
14/11.3/10
|
ENZAPROST T
|
None
|
-
|
Registered
|
Details →
|